Aetna Inc. v. Gilead Sciences, Inc.

District Court, N.D. California·Decided March 29, 2022·No. 3:21-cv-09827·Unknown

Opinion

STALEY, et al., Case No. 19-cv-02573-EMC

Plaintiffs, ORDER DENYING DEFENDANTS’ v. MOTION TO VACATE AETNA’S VOLUNTARY DISMISSAL GILEAD SCIENCES, INC., et al., Docket No. 863 Defendants.

Plaintiff, Case No. 21-cv-09827-EMC v.

GILEAD SCIENCES, INC., et al., Docket No. 19 Defendants.

The pending motion concerns Aetna v. Gilead, No. C-21-9827 EMC, which is one of the cases related to the main Staley action. This case shall hereinafter be referred to as Aetna I. Aetna filed Aetna I in state court, but Gilead removed the case to federal court. Aetna then moved to remand. The same day that Gilead’s opposition to the remand motion was due, Aetna filed a notice of voluntary dismissal pursuant to Federal Rule of Civil Procedure 41. Now pending before the Court is Gilead’s motion to vacate the voluntary dismissal. Having considered the parties’ briefs and accompanying submissions, as well as the oral argument of counsel, the Court hereby DENIES Defendants’ motion. /// /// The evidence of record reflects as follows. 12/14/2021. Aetna filed suit in state court against Gilead, BMS, and Janssen. Aetna asserted only state law claims. At or about the same time, Aetna’s counsel (the Crowell law firm) also filed a number of cases on behalf of other individual health plans in federal court. 12/20/2021. Gilead removed Aetna I to federal court. Gilead claimed both diversity jurisdiction and federal question jurisdiction as the basis for removal. On diversity jurisdiction, Gilead acknowledged that it is a citizen of California (i.e., a forum defendant) but asserted that removal was nevertheless proper because it had not yet been served. See Docket No. 1 (Not. of Removal at 1-2); 28 U.S.C. § 1441(b)(2) (“A civil action otherwise removable solely on the basis of the jurisdiction under section 1332(a) of this title [i.e., diversity jurisdiction] may not be removed if any of the parties in interest properly joined and served as defendants is a citizen of the State in which such action is brought.”) (emphasis added).1 On federal question jurisdiction, Gilead contended, inter alia, that substantial federal issues were raised regarding federal patent law, the Hatch-Waxman Act, and the FDA regulatory scheme and that the state law claims turned on federal antitrust law. 1/18/2022. Aetna filed a motion to remand. See Docket No. 12 (motion). The opposition was set to be filed on 2/1/2022. 1/31/2022. Aetna filed a new complaint in state court. That case shall hereinafter be referred to as Aetna II. The Aetna II complaint seems to be substantially the same as the Aetna I complaint. 2/1/2022. Before Gilead could file its opposition to the motion to remand in Aetna I, Aetna filed a notice of voluntary dismissal of Aetna I pursuant to Rule 41. See Docket No. 14 (notice); see also Fed. R. Civ. P. 41(a)(1)(A)(i) (“Subject to Rules 23(e), 23.1(c), 23.2, and 66 and

1 Gilead points out that this Court has previously stuck to the strict language of § 1441. See City of Ann Arbor Emples. Ret. Sys. v. Gecht, No. C-06-7453 EMC, 2007 U.S. Dist. LEXIS 21928, at *22, 24-25 (N.D. Cal. Mar. 9, 2007) (approving defendant’s removal of case to federal court; any applicable federal statute, the plaintiff may dismiss an action without a court order by filing: (i) a notice of dismissal before the opposing party serves either an answer or a motion for summary judgment.”). Thus, implicitly, Aetna was intending to proceed with Aetna II as its litigation vehicle rather than Aetna I. That same day, Gilead filed a statement indicating that it was looking into the propriety of the voluntary dismissal in Aetna I. See Docket No. 17 (response) (taking note that Aetna had recently filed the Aetna II complaint). 2/3/2022. Gilead removed Aetna II from state to federal court. See Aetna v. Gilead, No. C-22-0740 EMC (N.D. Cal.). 2/7/2022. In Aetna I, Defendants filed a motion to vacate the voluntary dismissal. This is the currently pending motion. 2/16/2022. In Aetna II, Defendants filed a motion to dismiss, which is currently set for hearing on 3/31/2022. The motion to dismiss is to be heard on the same day as other motions to dismiss filed in Staley (all challenging complaints filed by individual health plans). 3/2/2022. In Aetna II, Aetna filed a motion to remand its case back to state court. The motion is currently set for hearing on 4/7/2022. Federal Rule of Civil Procedure 41 provides in relevant part as follows: “Subject to Rules 23(e), 23.1(c), 23.2, and 66 and any applicable federal statute, the plaintiff may dismiss an action without a court order by filing: (i) a notice of dismissal before the opposing party serves either an answer or a motion for summary judgment.” Fed. R. Civ. P. 41(a)(1)(A)(i). In the instant case, there is no dispute that, at the time Aetna voluntarily dismissed Aetna I, no defendant had filed an answer or a motion for summary judgment. Defendants argue, however, that Aetna was not free to unilaterally voluntarily dismiss because Rule 41 says that a dismissal is subject to “any applicable federal statute.” According to Defendants, there is an applicable federal statute that prevents Aetna from unilaterally acting. Specifically, Defendants rely on the removal statutes /// /// themselves (28 U.S.C. §§ 1446-472) and the All Writs Act (id. § 16513). Citing, inter alia, Lou v. Belzberg, 834 F.2d 730 (9th Cir. 1987), Defendants argue that, because a court can – pursuant to the removal statutes – issue an injunction to prevent a party from subverting the court’s removal jurisdiction, this necessarily means that this Court can issue the “lesser remedy” of vacating Aetna’s voluntary dismissal which is intended to subvert the Court’s removal jurisdiction. The Court finds Defendants’ position unavailing. As a preliminary matter, it is notable that Defendants have not cited any authority holding that the removal statutes or the All Writs Act is an “applicable federal statute” for purposes of Rule 41. Nor was the Court able to find any such authority based on its independent research. In addition, the Court sees no principled reason to extend Rule 41 to include the removal statutes or the All Writs Act as an “applicable federal statute.” In assessing what could be an applicable federal statute, the Court takes guidance from Rule 41 which gives explicit examples 2 In its reply brief, Defendants relied on the following provisions specifically:

• Section 1446(d) which provides that “[p]romptly after the filing of such notice of removal of a civil action the defendant or defendants shall give written notice thereof to all adverse parties and shall file a copy of the notice with the clerk of such State court, which shall effect the removal and the State court shall proceed no further unless and until the case is remanded.” 28 U.S.C. § 1446(d). • Section 1447(a) which provides that, “[i]n any case removed from a State court, the district court may issue all necessary orders and process to bring before it all proper parties whether served by process issued by the State court or otherwise.” Id. § 1447(a).

See Reply at 2.

Free access — add to your briefcase to read the full text and ask questions with AI

Aetna Inc. v. Gilead Sciences, Inc., (N.D. Cal. 2022).

Aetna Inc. v. Gilead Sciences, Inc. (Aetna Inc. v. Gilead Sciences, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Kenney
550 F. Supp. 2d 118 (D. Maine, 2008)
American Soccer Co. v. Score First Enterprises
187 F.3d 1108 (Ninth Circuit, 1999)
Lou v. Belzberg
834 F.2d 730 (Ninth Circuit, 1987)